Literature DB >> 14755725

Clinical features of cerebral cavernous malformations patients with KRIT1 mutations.

Christian Denier1, Pierre Labauge, Laurent Brunereau, Florence Cavé-Riant, Florence Marchelli, Minh Arnoult, Michaelle Cecillon, Jacqueline Maciazek, Anne Joutel, Elisabeth Tournier-Lasserve.   

Abstract

Cerebral Cavernous Malformations (CCM/OMIM 604214) are vascular malformations causing seizures and cerebral hemorrhages. They occur as a sporadic and autosomal dominant condition, the latter being characterized by the presence of multiple CCM lesions. Stereotyped truncating mutations of KRIT1, the sole CCM gene identified so far, have been identified in CCM1 linked families but the clinical features associated with KRIT1 mutations have not yet been assessed in a large series of patients. We conducted a detailed clinical, neuroradiological and molecular analysis of 64 consecutively recruited CCM families segregating a KRIT1 mutation. Those families included 202 KRIT1 mutation carriers. Among the 202 KRIT1 mutation carriers, 126 individuals were symptomatic and 76 symptom-free. Mean age at clinical onset was 29.7 years (range, 2-72); initial clinical manifestations were seizures in 55% of the cases and cerebral hemorrhages in 32%. Average number of lesions on T2 weighted MRI was 4.9 (+/-7.2) and on gradient echo sequences 19.8 (+/-33.2). Twenty-six mutation carriers harbored only one lesion on T2-weighted MRI, including 4 mutation carriers, aged from 18 to 55 yr-old, who presented only one CCM lesion both on T2-weighted and on highly sensitive gradient echo MRI sequences. Five symptom free mutation carriers, aged from 27 to 48 yr-old, did not have any detectable lesion both on T2WI and gradient echo MRI sequences. Within KRIT1/CCM1 families, both clinical and radiological penetrance are incomplete and age dependent. Importantly for genetic counseling, nearly half of the KRIT1 mutation carriers aged 50 or more are symptom-free. The presence of only one lesion, even when using gradient echo MRI sequences, can be observed in some patients with an hereditary form of the disease. Incomplete neuroradiological penetrance precludes the use of cerebral MRI to firmly establish a non carrier status, even at an adult age and even when using highly sensitive gradient echo MRI. Altogether these data suggest that the hereditary nature of the disorder may be overlooked in some mutation carriers presenting as sporadic cases with a unique lesion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14755725     DOI: 10.1002/ana.10804

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  33 in total

Review 1.  Cavernous malformations of central nervous system in pediatric patients: our single-centered experience in 50 patients and review of literature.

Authors:  Dattaraj Paramanand Sawarkar; Suveen Janmatti; Rajinder Kumar; Pankaj Kumar Singh; Hitesh Kumar Gurjar; Shashank Sharad Kale; Bhawani Shanker Sharma; Ashok Kumar Mahapatra
Journal:  Childs Nerv Syst       Date:  2017-06-20       Impact factor: 1.475

2.  Identification of two novel mutations and of a novel critical region in the KRIT1 gene.

Authors:  Vito Guarnieri; Lucia A Muscarella; Rosina Amoroso; Alessandro Quattrone; Massimo E Abate; Michelina Coco; Domenico Catapano; Vincenzo A D'Angelo; Leopoldo Zelante; Leonardo D'Agruma
Journal:  Neurogenetics       Date:  2006-10-17       Impact factor: 2.660

Review 3.  Genetics of cerebral cavernous malformations: current status and future prospects.

Authors:  H Choquet; L Pawlikowska; M T Lawton; H Kim
Journal:  J Neurosurg Sci       Date:  2015-04-22       Impact factor: 2.279

4.  Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation.

Authors:  Hélène Choquet; Jeffrey Nelson; Ludmila Pawlikowska; Charles E McCulloch; Amy Akers; Beth Baca; Yasir Khan; Blaine Hart; Leslie Morrison; Helen Kim
Journal:  Cerebrovasc Dis       Date:  2013-12-21       Impact factor: 2.762

5.  Familial Cerebral Cavernous Malformations Are Associated with Adrenal Calcifications on CT Scans: An Imaging Biomarker for a Hereditary Cerebrovascular Condition.

Authors:  Corinne D Strickland; Steven C Eberhardt; Mary R Bartlett; Jeffrey Nelson; Helen Kim; Leslie A Morrison; Blaine L Hart
Journal:  Radiology       Date:  2017-03-20       Impact factor: 11.105

Review 6.  Rho kinase as a target for cerebral vascular disorders.

Authors:  Lisa M Bond; James R Sellers; Lisa McKerracher
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

Review 7.  Update on intracerebral haemorrhage.

Authors:  José M Ferro
Journal:  J Neurol       Date:  2006-05-06       Impact factor: 4.849

8.  Genetic Insights into Cerebrovascular Disorders: A Comprehensive Review.

Authors:  Fawaz Al-Mufti; Ahmed Alkanaq; Krishna Amuluru; Rolla Nuoman; Ahmed Abdulrazzaq; Tamarah Sami; Halla Nuoaman; Caroline Hayes-Rosen; Charles J Prestigiacomo; Chirag D Gandhi
Journal:  J Vasc Interv Neurol       Date:  2017-10

Review 9.  Cerebral Cavernous Malformations: An Update on Prevalence, Molecular Genetic Analyses, and Genetic Counselling.

Authors:  Stefanie Spiegler; Matthias Rath; Christin Paperlein; Ute Felbor
Journal:  Mol Syndromol       Date:  2018-01-25

10.  Cutaneous venous malformations in familial cerebral cavernomatosis caused by KRIT1 gene mutations.

Authors:  Agustí Toll; Elisabet Parera; Ana M Giménez-Arnau; Alejandro Pou; Josep Lloreta; Nisha Limaye; Miikka Vikkula; Ramon M Pujol
Journal:  Dermatology       Date:  2009-01-31       Impact factor: 5.366

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.